De afecciones oculares a menstruales: las complicaciones de los nuevos medicamentos para bajar de peso que pocos conocen
- Words
- 33
- Chars
- 238
- AI summary
- Yes
Full story
European drug regulators found sufficient evidence of a causal link between semaglutide and ocular infarction. This finding was concluded last year. These weight loss medications are associated with various complications. Some of these effects involve eye conditions, while others relate to menstrual issues. Investigators are currently looking into other potential side effects of the drugs.
Los reguladores de medicamentos europeos concluyeron el año pasado que la evidencia era suficiente para establecer una relación causal entre la semaglutida y el infarto ocular (Noia-NA); otros efectos secundarios están siendo investigados
Open article